Alpha-adrenergic inhibition increases collateral circuit conductance in rats following acute occlusion of the femoral artery.

Jessica C Taylor, Zeyi Li, H T Yang, M Harold Laughlin, Ronald L Terjung
Author Information
  1. Jessica C Taylor: Department of Biomedical Sciences, E102 Vet. Medical Bldg, University of Missouri, Columbia, MO 65211, USA.

Abstract

This study evaluated whether alpha-adrenergic activation contributes to collateral circuit vascular resistance in the hindlimb following acute unilateral occlusion of the femoral artery in rats. Blood pressures (BPs) were measured above (caudal artery) and below (distal femoral artery) the collateral circuit. Arterial BPs were reduced (15-35 mmHg) with individual (prazosin, rauwolscine) or combined (phentolamine) alpha-receptor inhibition. Blood flows (BFs) were measured using microspheres before and after alpha inhibition during the same treadmill speed. alpha(1) inhibition increased blood flow by approximately 40% to active muscles that were not affected by femoral occlusion, whereas collateral-dependent BFs to the calf muscles were reduced by 29 +/- 8.4% (P < 0.05), due to a decrease in muscle conductance with no change in collateral circuit conductance. alpha(2) inhibition decreased both collateral circuit (39 +/- 6.0%; P < 0.05) and calf muscle conductance (36 +/- 7.3%; P < 0.05), probably due to residual alpha(1) activation, since renal BF was markedly reduced with rauwolscine. Most importantly, inhibiting alpha(2) receptors in the presence of alpha(1) inhibition increased (43 +/- 12%; P < 0.05) collateral circuit conductance. Similarly, non-selective alpha inhibition with phentolamine increased collateral conductance (242 +/- 59%; P < 0.05). We interpret these findings to indicate that both alpha(1)- and alpha(2)-receptor activation can influence collateral circuit resistance in vivo during the high flow demands caused by exercise. Furthermore, we observed a reduced maximal conductances of active muscles that were ischaemic. Our findings imply that in the presence of excessive sympathetic activation, which can occur in the condition of intermittent claudication during exertion, an exaggerated vasoconstriction of the existing collateral circuit and active muscle will occur.

References

  1. N Engl J Med. 2002 Dec 12;347(24):1941-51 [PMID: 12477945]
  2. Circ Res. 1992 Mar;70(3):546-53 [PMID: 1537090]
  3. Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R228-33 [PMID: 15044188]
  4. Eur J Pharmacol. 1981 Dec 17;76(4):461-4 [PMID: 6276200]
  5. Phys Sportsmed. 1982 May;10(5):90-101 [PMID: 29278187]
  6. J Appl Physiol Respir Environ Exerc Physiol. 1983 Oct;55(4):1072-8 [PMID: 6313564]
  7. Auton Neurosci. 2004 May 31;112(1-2):15-24 [PMID: 15233926]
  8. Circ Res. 1968 Aug;23(2):239-48 [PMID: 5662576]
  9. J Appl Physiol (1985). 2002 Jun;92(6):2452-6 [PMID: 12015359]
  10. J Physiol. 2002 Nov 1;544(3):977-84 [PMID: 12411540]
  11. Am J Physiol Heart Circ Physiol. 2000 Jan;278(1):H85-93 [PMID: 10644587]
  12. Am J Physiol. 1989 Dec;257(6 Pt 2):H1958-65 [PMID: 2603980]
  13. J Pathol. 2000 Feb;190(3):338-42 [PMID: 10685067]
  14. Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2434-47 [PMID: 15271665]
  15. Am J Physiol. 1996 Sep;271(3 Pt 2):H914-23 [PMID: 8853325]
  16. Am J Physiol. 1990 Mar;258(3 Pt 2):H759-65 [PMID: 2316692]
  17. Am J Physiol. 1995 Mar;268(3 Pt 2):H1174-80 [PMID: 7900871]
  18. Am J Physiol. 1983 Aug;245(2):H265-75 [PMID: 6881361]
  19. Cardiovasc Res. 2001 Jan;49(1):218-25 [PMID: 11121814]
  20. News Physiol Sci. 1999 Jun;14:121-125 [PMID: 11390835]
  21. Am J Physiol Heart Circ Physiol. 2000 Jun;278(6):H1966-73 [PMID: 10843895]
  22. Am J Physiol. 1986 Nov;251(5 Pt 2):H1038-44 [PMID: 3777192]
  23. J Vasc Surg. 2000 Jan;31(1 Pt 2):S1-S296 [PMID: 10666287]
  24. Klin Wochenschr. 1991 Apr 4;69(6):233-8 [PMID: 2038172]
  25. J Cardiovasc Pharmacol. 1984 Sep-Oct;6(5):961-8 [PMID: 6209507]
  26. Circ Res. 1983 Jul;53(1):8-15 [PMID: 6861299]
  27. J Cardiovasc Pharmacol. 1983 Nov-Dec;5(6):989-97 [PMID: 6196572]
  28. J Appl Physiol (1985). 1993 Jul;75(1):452-7 [PMID: 8397181]
  29. Biochem Biophys Res Commun. 1985 Nov 27;133(1):30-6 [PMID: 3840999]
  30. J Cardiovasc Pharmacol. 1984;6 Suppl 4:S547-58 [PMID: 6210422]
  31. Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1890-7 [PMID: 11009477]
  32. Am J Physiol. 1993 Nov;265(5 Pt 2):H1501-9 [PMID: 8238561]
  33. J Appl Physiol (1985). 1997 Nov;83(5):1575-80 [PMID: 9375322]
  34. Eur J Vasc Endovasc Surg. 2007 Jan;33(1):20-5 [PMID: 16934498]
  35. J Surg Res. 1996 May;62(2):192-6 [PMID: 8632638]
  36. Br J Pharmacol. 1977 Mar;59(3):514P-515P [PMID: 14760]
  37. Am J Physiol Heart Circ Physiol. 2002 Jan;282(1):H301-10 [PMID: 11748075]
  38. Am J Physiol. 1982 Aug;243(2):H296-306 [PMID: 7114239]
  39. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jun;52(6):1629-35 [PMID: 7107472]
  40. J Appl Physiol (1985). 1995 Jul;79(1):73-82 [PMID: 7559251]
  41. J Clin Invest. 2003 Jun;111(12):1853-62 [PMID: 12813021]
  42. Regul Pept. 1987 Dec;19(5-6):313-24 [PMID: 3438489]
  43. Acta Physiol Scand. 1977 Jul;100(3):288-97 [PMID: 920199]
  44. J Appl Physiol (1985). 1998 Aug;85(2):609-18 [PMID: 9688739]
  45. J Appl Physiol (1985). 1988 Jul;65(1):434-40 [PMID: 3403486]
  46. Circ Res. 1986 Aug;59(2):133-42 [PMID: 2874899]
  47. Br J Pharmacol. 1997 Feb;120(3):387-92 [PMID: 9031740]
  48. Am J Physiol. 1997 Sep;273(3 Pt 2):H1255-65 [PMID: 9321814]
  49. Circ Res. 1996 Jul;79(1):62-9 [PMID: 8925570]
  50. Am J Physiol. 1987 Sep;253(3 Pt 2):H582-90 [PMID: 2888319]
  51. Eur J Vasc Endovasc Surg. 2000 Apr;19(4):387-95 [PMID: 10801372]
  52. J Appl Physiol (1985). 2005 Dec;99(6):2115-20 [PMID: 16099895]

Grants

  1. R01 HL037387/NHLBI NIH HHS
  2. R01-HL37387/NHLBI NIH HHS
  3. T32-AR48523/NIAMS NIH HHS
  4. R01 HL036088/NHLBI NIH HHS
  5. R01-HL36088/NHLBI NIH HHS
  6. T32 AR048523/NIAMS NIH HHS

MeSH Term

Animals
Blood Flow Velocity
Blood Pressure
Femoral Artery
Male
Muscle, Skeletal
Physical Exertion
Rats
Rats, Sprague-Dawley
Receptors, Adrenergic, alpha
Sympathetic Nervous System
Vascular Resistance
Vasoconstriction

Chemicals

Receptors, Adrenergic, alpha

Word Cloud

Created with Highcharts 10.0.0collateralalphacircuitinhibitionconductance+/-P<005activationfemoralarteryreduced1occlusionincreasedactivemusclesmuscle2resistancefollowingacuteratsBloodBPsmeasuredrauwolscinephentolamineBFsflowcalfduepresencefindingscanoccurstudyevaluatedwhetheralpha-adrenergiccontributesvascularhindlimbunilateralpressurescaudaldistalArterial15-35mmHgindividualprazosincombinedalpha-receptorflowsusingmicrospherestreadmillspeedbloodapproximately40%affectedwhereascollateral-dependent2984%decreasechangedecreased3960%3673%probablyresidualsincerenalBFmarkedlyimportantlyinhibitingreceptors4312%Similarlynon-selective24259%interpretindicate--receptorinfluencevivohighdemandscausedexerciseFurthermoreobservedmaximalconductancesischaemicimplyexcessivesympatheticconditionintermittentclaudicationexertionexaggeratedvasoconstrictionexistingwillAlpha-adrenergicincreases

Similar Articles

Cited By (19)